Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

NCT01947959 · clinicaltrials.gov ↗

COMPLETED

Status

665533

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis
Pulmonary Embolism
Atrial Fibrillation
Acute Coronary Syndrome

Interventions

DRUG: Rivaroxaban (Xarelto, Bay59-7939)
DRUG: Standard of care

Sponsor

Bayer

Collaborators

[object Object]